These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31298602)

  • 1. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
    Schierle S; Merk D
    Expert Opin Ther Pat; 2019 Aug; 29(8):605-621. PubMed ID: 31298602
    [No Abstract]   [Full Text] [Related]  

  • 2. Retinoid X receptor ligands: a patent review (2007 - 2013).
    Yamada S; Kakuta H
    Expert Opin Ther Pat; 2014 Apr; 24(4):443-52. PubMed ID: 24456080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of "rexinoids" in cancer prevention and treatment.
    Tanaka T; De Luca LM
    Cancer Res; 2009 Jun; 69(12):4945-7. PubMed ID: 19509234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties.
    Lewandowski M; Carmina M; Knümann L; Sai M; Willems S; Kasch T; Pollinger J; Knapp S; Marschner JA; Chaikuad A; Merk D
    J Med Chem; 2024 Feb; 67(3):2152-2164. PubMed ID: 38237049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand Design for Modulation of RXR Functions.
    Martínez C; Souto JA; de Lera AR
    Methods Mol Biol; 2019; 2019():51-72. PubMed ID: 31359388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods to Generate an Array of Novel Rexinoids by SAR on a Potent Retinoid X Receptor Agonist: A Case Study with NEt-TMN.
    Wagner CE; Jurutka PW
    Methods Mol Biol; 2019; 2019():109-121. PubMed ID: 31359392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid X Receptor agonists as selective modulators of the immune system for the treatment of cancer.
    Leal AS; Hung PY; Chowdhury AS; Liby KT
    Pharmacol Ther; 2023 Dec; 252():108561. PubMed ID: 37952906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity.
    Morishita KI; Kakuta H
    Curr Top Med Chem; 2017; 17(6):696-707. PubMed ID: 27320332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural and Structure-based RXR Ligand Scaffolds and Their Functions.
    Dominguez M; Alvarez S; de Lera AR
    Curr Top Med Chem; 2017; 17(6):631-662. PubMed ID: 27320335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in the Design and Discovery of RXR Modulators Targeting Alternate Binding Sites of the Receptor.
    Su Y; Zeng Z; Chen Z; Xu D; Zhang W; Zhang XK
    Curr Top Med Chem; 2017; 17(6):663-675. PubMed ID: 27320331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in studies on selective RXR ligands].
    Mei JH; Wang MW
    Yao Xue Xue Bao; 2005 Apr; 40(4):294-8. PubMed ID: 16011254
    [No Abstract]   [Full Text] [Related]  

  • 13. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands.
    Crowe DL; Chandraratna RA
    Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB).
    Jurutka PW; di Martino O; Reshi S; Mallick S; Sabir ZL; Staniszewski LJP; Warda A; Maiorella EL; Minasian A; Davidson J; Ibrahim SJ; Raban S; Haddad D; Khamisi M; Suban SL; Dawson BJ; Candia R; Ziller JW; Lee MY; Liu C; Liu W; Marshall PA; Welch JS; Wagner CE
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative retinoid X receptor (RXR) ligands.
    Krężel W; Rühl R; de Lera AR
    Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation.
    Pollinger J; Gellrich L; Schierle S; Kilu W; Schmidt J; Kalinowsky L; Ohrndorf J; Kaiser A; Heering J; Proschak E; Merk D
    J Med Chem; 2019 Feb; 62(4):2112-2126. PubMed ID: 30702885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences.
    Pollinger J; Schierle S; Gellrich L; Ohrndorf J; Kaiser A; Heitel P; Chaikuad A; Knapp S; Merk D
    ACS Med Chem Lett; 2019 Sep; 10(9):1346-1352. PubMed ID: 31531208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential therapeutic uses of rexinoids.
    Leal AS; Reich LA; Moerland JA; Zhang D; Liby KT
    Adv Pharmacol; 2021; 91():141-183. PubMed ID: 34099107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioligand binding assay for accurate determination of nuclear retinoid X receptors: A case of triorganotin endocrine disrupting ligands.
    Toporova L; Macejova D; Brtko J
    Toxicol Lett; 2016 Jul; 254():32-6. PubMed ID: 27153798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning RXR Modulators for PGC1α Recruitment.
    Nawa F; Sai M; Vietor J; Schwarzenbach R; Bitić A; Wolff S; Ildefeld N; Pabel J; Wein T; Marschner JA; Heering J; Merk D
    J Med Chem; 2024 Sep; 67(18):16338-16354. PubMed ID: 39258574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.